HomeOp-Ed340B needs to return to its roots: serving the country's most vulnerable...

340B needs to return to its roots: serving the country’s most vulnerable patients

No older adult should have to choose between filling a prescription and paying for groceries or keeping the lights on. Yet that’s precisely the choice too many older adults in the United States — especially Hispanic adults — face.

By Yanira Cruz
More than one in five Medicare beneficiaries say they have recently delayed or skipped needed care because of cost. Hispanic older adults, in particular, go without treatment at disproportionately high rates.

More than three decades ago, Congress created a program to help these patients. The 340B Drug Pricing Program requires pharmaceutical manufacturers to provide steep discounts on medicines to certain hospitals, clinics, and other safety-net providers. In theory, they can use those discounts to reinvest in the patient community they serve by offering services that don’t deliver much financial return, but provide enormous value to struggling communities.  
Unfortunately, despite their good intentions, lawmakers never established tough guardrails or oversight mechanisms to ensure hospitals actually use the program to help people, rather than just padding their own bottom lines. 
So right now, many hospitals purchase discounted medicines and then resell them at significant markups to more affluent, insured patients.
340B has grown far larger than lawmakers initially envisioned. At the outset, they expected the program would enroll about 200 hospitals. The program immediately grew beyond initial projections — and then kept booming. In 2010, hospitals and other “covered entities” purchased $6.6 billion of medicines through the program. By 2021, that figure had grown to $43.9 billion. By 2025, purchases had surpassed $100 billion. 

Patients largely haven’t benefited from those discounts, though. In fact, the program is actively hurting many vulnerable communities — by giving hospitals an incentive to partner with for-profit “contract pharmacies” in wealthier areas, so that hospitals can route more prescriptions to patients with private insurance that will pay the steep markups hospitals demand. 
A JAMA Health Forum study found that as 340B contract pharmacy arrangements expanded, the share of participating pharmacies in predominantly Hispanic or Latino neighborhoods declined. Growth concentrated in more affluent and predominantly white communities.

That trend is troubling, especially given the financial pressures many Hispanic families face. Two in five who delayed or skipped care because of cost said their health worsened as a result.

Congress now has an opportunity to get 340B back on track. Recently, lawmakers from both parties have introduced proposals that’d require hospitals to disclose how they use their 340B savings, and what portion directly supports patients. Accountability and transparent measures like these would help reduce patients’ pharmacy bills — and help ensure their local pharmacies remain afloat in the face of competition from big national chains exploiting the 340B program. 

Dr. Yanira Cruz is the President and CEO of the National Hispanic Council on Aging. This column originally appeared at DCJournal.com
Advertisement
RELATED ARTICLES

LEAVE A REPLY

Please enter your comment!
Please enter your name here

- Advertisment -

Most Popular

Recent Comments

MatthewFaW on Contact Us
gealt on Contact Us
CRYSTAL GARCIA on Contact Us
Joseph Cromwell on COMMENTARY: If Trump Loses
Ayana Davenport on Contact Us
Michael Epton on Contact Us
William E. Gilg on Our Editorial Standards